Literature DB >> 21511948

The G82S polymorphism promotes glycosylation of the receptor for advanced glycation end products (RAGE) at asparagine 81: comparison of wild-type rage with the G82S polymorphic variant.

Sun Jin Park1, Torsten Kleffmann, Paul A Hessian.   

Abstract

Interaction between the receptor for advanced glycation end products (RAGE) and its ligands amplifies the proinflammatory response. N-Linked glycosylation of RAGE plays an important role in the regulation of ligand binding. Two potential sites for N-linked glycosylation, at Asn(25) and Asn(81), are implicated, one of which is potentially influenced by a naturally occurring polymorphism that substitutes Gly(82) with Ser. This G82S polymorphic RAGE variant displays increased ligand binding and downstream signaling. We hypothesized that the G82S polymorphism affects RAGE glycosylation and thereby affects ligand binding. WT or various mutant forms of RAGE protein, including N25Q, N81Q, N25Q/G82S, and N25Q/N81Q, were produced by transfecting HEK293 cells. The glycosylation patterns of expressed proteins were compared. Enzymatic deglycosylation showed that WT RAGE and the G82S polymorphic variant are glycosylated to the same extent. Our data also revealed N-linked glycosylation of N25Q and N81Q mutants, suggesting that both Asn(25) and Asn(81) can be utilized for N-linked glycosylation. Using mass spectrometry analysis, we found that Asn(81) may or may not be glycosylated in WT RAGE, whereas in G82S RAGE, Asn(81) is always glycosylated. Furthermore, RAGE binding to S100B ligand is affected by Asn(81) glycosylation, with consequences for NF-κB activation. Therefore, the G82S polymorphism promotes N-linked glycosylation of Asn(81), which has implications for the structure of the ligand binding region of RAGE and might explain the enhanced function associated with the G82S polymorphic RAGE variant.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21511948      PMCID: PMC3122198          DOI: 10.1074/jbc.M111.241281

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.

Authors:  M A Hofmann; S Drury; C Fu; W Qu; A Taguchi; Y Lu; C Avila; N Kambham; A Bierhaus; P Nawroth; M F Neurath; T Slattery; D Beach; J McClary; M Nagashima; J Morser; D Stern; A M Schmidt
Journal:  Cell       Date:  1999-06-25       Impact factor: 41.582

Review 2.  RAGE: a novel cellular receptor for advanced glycation end products.

Authors:  A M Schmidt; O Hori; R Cao; S D Yan; J Brett; J L Wautier; S Ogawa; K Kuwabara; M Matsumoto; D Stern
Journal:  Diabetes       Date:  1996-07       Impact factor: 9.461

3.  18O-labeling of N-glycosylation sites to improve the identification of gel-separated glycoproteins using peptide mass mapping and database searching.

Authors:  B Küster; M Mann
Journal:  Anal Chem       Date:  1999-04-01       Impact factor: 6.986

4.  Novel carboxylated N-glycans contain oligosaccharide-linked glutamic acid.

Authors:  Geetha Srikrishna; Lena Brive; Hudson H Freeze
Journal:  Biochem Biophys Res Commun       Date:  2005-07-15       Impact factor: 3.575

5.  RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

Authors:  S D Yan; X Chen; J Fu; M Chen; H Zhu; A Roher; T Slattery; L Zhao; M Nagashima; J Morser; A Migheli; P Nawroth; D Stern; A M Schmidt
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

6.  An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease.

Authors:  S D Yan; J Fu; C Soto; X Chen; H Zhu; F Al-Mohanna; K Collison; A Zhu; E Stern; T Saido; M Tohyama; S Ogawa; A Roher; D Stern
Journal:  Nature       Date:  1997-10-16       Impact factor: 49.962

7.  Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.

Authors:  A M Schmidt; O Hori; J X Chen; J F Li; J Crandall; J Zhang; R Cao; S D Yan; J Brett; D Stern
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

8.  The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system.

Authors:  O Hori; J Brett; T Slattery; R Cao; J Zhang; J X Chen; M Nagashima; E R Lundh; S Vijay; D Nitecki
Journal:  J Biol Chem       Date:  1995-10-27       Impact factor: 5.157

Review 9.  Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups.

Authors:  B I Hudson; M H Stickland; P J Grant
Journal:  Diabetes       Date:  1998-07       Impact factor: 9.461

10.  Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.

Authors:  Rille Pullerits; Maria Bokarewa; Leif Dahlberg; Andrej Tarkowski
Journal:  Arthritis Res Ther       Date:  2005-04-25       Impact factor: 5.156

View more
  24 in total

1.  Relationship between RAGE gene polymorphisms and cardiovascular disease prognosis in the Chinese Han population.

Authors:  Jinxiong Gao; Liehua Deng; Ying Wang; Yanke Shi; Xiaohua Xiao; Xueou Zheng; Hao Ren; Dingli Xu
Journal:  Mol Genet Genomics       Date:  2017-06-28       Impact factor: 3.291

Review 2.  RAGE: a new frontier in chronic airways disease.

Authors:  Maria B Sukkar; Md Ashik Ullah; Wan Jun Gan; Peter A B Wark; Kian Fan Chung; J Margaret Hughes; Carol L Armour; Simon Phipps
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 3.  RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer-a Review.

Authors:  Gowri Palanissami; Solomon F D Paul
Journal:  Horm Cancer       Date:  2018-07-09       Impact factor: 3.869

4.  Insights into the effects of N-glycosylation on the characteristics of the VC1 domain of the human receptor for advanced glycation end products (RAGE) secreted by Pichia pastoris.

Authors:  Genny Degani; Alberto Barbiroli; Paula Magnelli; Stefania Digiovanni; Alessandra Altomare; Giancarlo Aldini; Laura Popolo
Journal:  Glycoconj J       Date:  2019-01-05       Impact factor: 2.916

Review 5.  Applying Functional Genomics to Chronic Obstructive Pulmonary Disease.

Authors:  Edwin K Silverman
Journal:  Ann Am Thorac Soc       Date:  2018-12

6.  Determinants of concentrations of N(ε)-carboxymethyl-lysine and soluble receptor for advanced glycation end products and their associations with risk of pancreatic cancer.

Authors:  Zhigang Duan; Guoqing Chen; Liang Chen; Rachael Stolzenberg-Solomon; Stephanie J Weinstein; Satu Mannisto; Donna L White; Demetrius Albanes; Li Jiao
Journal:  Int J Mol Epidemiol Genet       Date:  2014-10-22

7.  Soluble receptor and gene polymorphism for AGE: relationship with obesity and cardiovascular risks.

Authors:  Mohamed Rowisha; Manal El-Batch; Thanaa El Shikh; Salwa El Melegy; Hany Aly
Journal:  Pediatr Res       Date:  2016-03-18       Impact factor: 3.756

8.  Exome Array Analysis Identifies a Common Variant in IL27 Associated with Chronic Obstructive Pulmonary Disease.

Authors:  Brian D Hobbs; Margaret M Parker; Han Chen; Taotao Lao; Megan Hardin; Dandi Qiao; Iwona Hawrylkiewicz; Pawel Sliwinski; Jae-Joon Yim; Woo Jin Kim; Deog Kyeom Kim; Peter J Castaldi; Craig P Hersh; Jarrett Morrow; Bartolome R Celli; Victor M Pinto-Plata; Gerald J Criner; Nathaniel Marchetti; Raphael Bueno; Alvar Agustí; Barry J Make; James D Crapo; Peter M Calverley; Claudio F Donner; David A Lomas; Emiel F M Wouters; Jorgen Vestbo; Peter D Paré; Robert D Levy; Stephen I Rennard; Xiaobo Zhou; Nan M Laird; Xihong Lin; Terri H Beaty; Edwin K Silverman; Michael H Cho
Journal:  Am J Respir Crit Care Med       Date:  2016-07-01       Impact factor: 21.405

9.  Homeostatic nuclear RAGE-ATM interaction is essential for efficient DNA repair.

Authors:  Varun Kumar; Thomas Fleming; Stefan Terjung; Christian Gorzelanny; Christoffer Gebhardt; Raman Agrawal; Marcus A Mall; Julia Ranzinger; Martin Zeier; Thati Madhusudhan; Satish Ranjan; Berend Isermann; Arthur Liesz; Divija Deshpande; Hans-Ulrich Häring; Subrata K Biswas; Paul R Reynolds; Hans-Peter Hammes; Rainer Peperkok; Peter Angel; Stephan Herzig; Peter P Nawroth
Journal:  Nucleic Acids Res       Date:  2017-10-13       Impact factor: 16.971

10.  The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth.

Authors:  Hyun-Jin Tae; Ji Min Kim; Sungha Park; Noboru Tomiya; Geng Li; Wen Wei; Natalia Petrashevskaya; Ismayil Ahmet; John Pang; Stefanie Cruschwitz; Rebecca A Riebe; Yinghua Zhang; Christopher H Morrell; David Browe; Yuan Chuan Lee; Rui-ping Xiao; Mark I Talan; Edward G Lakatta; Li Lin
Journal:  J Mol Med (Berl)       Date:  2013-10-17       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.